Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/01/2007US20070049629 Non-Steroidal Antiandrogens
03/01/2007US20070049628 Benzoxazole inhibitors of 15-lipoxygenase
03/01/2007US20070049627 Treating vulvodynia using prodrugs of GABA analogs
03/01/2007US20070049626 Treating premature ejaculation using gabapentin and pregabalin prodrugs
03/01/2007US20070049625 3-{[(4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid; post-surgical and post-laser trabeculectomy ocular hypertensive episodes, presurgical adjuncts
03/01/2007US20070049624 a mixture of 1-(4-hydroxyphenyl)-5-methylpyridin-2-one and pharmaceutically-acceptable excipients, used foro the treatment of liver fibrosis
03/01/2007US20070049623 1-(Hetero)aryl- and 3-substituted with a group containing an arylaldehyde oxime, e.g., 4-[5-(2-oxo-3-pyridin-4-yl-imidazolidin-1-yl)-pentyloxy]-benzaldehyde O-methyl-oxime; treating enteroviral infections
03/01/2007US20070049622 Substituted benzimidazoles and methods of preparation
03/01/2007US20070049621 6-Alkylamino-2-methyl-2'-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative as anti-inflammatory inhibitor
03/01/2007US20070049620 Cyclic tertiary amine compound
03/01/2007US20070049619 e.g. 3-((S)-2-amino-2-{trans-4-[4-(5-cyano-2-pyridinyl)-1-piperazinyl]-1-cyclohexyl}acetyl)-1,3-thiazolidine; dipeptidyl-peptidases inhibitor; suppress cleavage of glucagon-like peptides (GLP-1) by inhibition of DPP-IV; antidiabetic agent; obesity, non insulin-dependent diabetes
03/01/2007US20070049618 Isoindole-imide compounds and compositions comprising and methods of using the same
03/01/2007US20070049617 aqueous, stable, injectable, sterile pharmaceutical solution containing an acid to solubilize the argatroban, free from dehydrated alcohol; sodium chloride osmotic-adjusting agent to enhance infusion properties; storage stable; anticoagulants
03/01/2007US20070049616 Organic compounds
03/01/2007US20070049615 3-(6-Chloro-pyridin-3-ylmethyl)-4-phenyl-1H-pyrrolo[2,3-b]pyridine; molecular scaffolds
03/01/2007US20070049614 Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject
03/01/2007US20070049613 cis-6-(2,4-Dichloro-phenyl)-1,2,3,4,4a,9a-hexahydro-3-aza-fluoren-9-one, used for treating metabolic disorders, nervous system disorders, headaches, gastrointestinal disorders and as analgesics
03/01/2007US20070049612 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
03/01/2007US20070049611 Phosphodiesterase 4 inhibitors
03/01/2007US20070049610 Diaminopyrimidines as P2X3 and P2X2/3 modulators
03/01/2007US20070049609 Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
03/01/2007US20070049608 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
03/01/2007US20070049607 Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists
03/01/2007US20070049606 Bicyclic heterocycles as HIV-integrase inhibitors
03/01/2007US20070049605 5H-Dibenzo[c,g]chromene-3,9-diol; estrogen receptor modulators; osteoporosis
03/01/2007US20070049604 Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof
03/01/2007US20070049603 Raf inhibitor compounds and methods of use thereof
03/01/2007US20070049602 Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3
03/01/2007US20070049601 BENZOFURAN INHIBITORS OF FACTOR VIIa
03/01/2007US20070049600 Pteridinones as kinase inhibitors
03/01/2007US20070049599 Use of bh4 for the treatment of respiratory diseases
03/01/2007US20070049598 preferential enzyme inhibitors comprising fused pyrazolo derivatives, used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease
03/01/2007US20070049597 p38 MAP kinase inhibitors and methods for using the same
03/01/2007US20070049596 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
03/01/2007US20070049595 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; osteoporosis
03/01/2007US20070049594 Novel compounds and compositions as cathepsin inhibitors
03/01/2007US20070049593 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
03/01/2007US20070049592 Bis-aryl urea compounds and methods of use
03/01/2007US20070049591 Inhibitors of MAPK/Erk Kinase
03/01/2007US20070049590 Compositions comprising zopiclone derivatives and methods of making and using the same
03/01/2007US20070049589 N-(4-{N'-[2-(6-Bromo-1H-indol-3-yl)-acetyl]-guanidinomethyl}-2,6-dichloro-phenyl)-acetamide, for example; useful in the treatment of neurological disorders related to beta-amyloid production, particularly, treatment of Alzheimer's Disease and similar diseases
03/01/2007US20070049588 Atm inhibitor
03/01/2007US20070049587 Factor Xa inhibitors
03/01/2007US20070049586 8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
03/01/2007US20070049585 Benzamide and benzoate anti-hiv compounds
03/01/2007US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
03/01/2007US20070049583 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents
03/01/2007US20070049582 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
03/01/2007US20070049581 (R)-2-(1'-carboxymethyl-4,4'-bipiperidinyl-1-yl)-1-(3-chloro-4-hydroxy-5-methyl-benzyl)-2-oxo-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine, headaches, non-insulin-dependent diabetes, irritable bowel syndrome
03/01/2007US20070049580 Anxiolytic agents with reduced sedative and ataxic effects
03/01/2007US20070049579 Medicament having neovascularization promoting action
03/01/2007US20070049578 Cinnamamide compounds as metabotropic glutamate receptor antagonists
03/01/2007US20070049577 CGRP antagonists
03/01/2007US20070049576 Neurogenesis by muscarinic receptor modulation
03/01/2007US20070049575 Reacting 2-carboxamidoethyl-Indolecarboxylic acid compound with methyl sulfonic acid and phosphorus pentoxide, reacting resulting indoloazepine compound with phenyl oxazolone and a transition metal catalyst, reacting resulting compound with with thiourea and a base in a solvent
03/01/2007US20070049574 4,5-Dicyclopropyl-1-methyl-2-phenyl-1,2-dihydro-pyrazol-3-one; 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1); 4-Cyclopropyl-5-(2,2-difluoro-cyclopropyl)-1-methyl-2-(2-trifluoromethyl-phenyl)-1,2-dihydro-pyrazol-3-one;
03/01/2007US20070049573 Pyrrole-Derivatives as Factor Xa Inhibitors
03/01/2007US20070049572 4-(Piperidinomethylaminosulfonyl),7-(methoxy-)-1,4-benzothiazepineprepared by the reaction of 7-(methoxy-)-1,4-benzothiazepine andpiperidinomethylaminosulfonyl chloride using a basic catalyst; ranodinereceptors that regulate calcium channel functioning in cells; skeletal muscular, cardiac disorders
03/01/2007US20070049571 Dipiperazinyl ketones and related analogues
03/01/2007US20070049570 Quinoline derivatives as phosphodiesterase inhibitors
03/01/2007US20070049569 Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
03/01/2007US20070049568 Control of induced elevated intraocular pressure
03/01/2007US20070049567 Hormone replacement composition and method
03/01/2007US20070049566 Methods and Compositions for inhibition of angiogenesis
03/01/2007US20070049565 For example NEU 2000, 2-hydroxy-5-(2-(4-trifluoromethyl-phenyl)ethylamino)-benzoic acid; Alzheimer's disease, Parkinson's disease, traumatic brain injury or spinal cord injury; and eye disorders such as glaucoma, diabetic retinopathy or macular degeneration
03/01/2007US20070049564 9-Aminocarbonylsubstituted derivatives of glycylcyclines
03/01/2007US20070049563 Nitrating a minocycline, reducing to form 9-aminominocycline with is then amidated to form e.g. tigecycline hydrochloride
03/01/2007US20070049562 Tigecycline and methods of preparation
03/01/2007US20070049561 Methods of purifying tigecycline
03/01/2007US20070049560 Synthesis of tigecycline hydrochloride, purity, industrial scale
03/01/2007US20070049559 Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of Gelatinase A in ocular cells
03/01/2007US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors
03/01/2007US20070049557 Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
03/01/2007US20070049556 Novel benzopyran derivatives as potassium channel openers
03/01/2007US20070049555 Indenoisoquinolinone analogs and methods of use thereof
03/01/2007US20070049554 Method for treatment or prevention of conditions caused by gram-positive bacteria
03/01/2007US20070049553 Amino Sugar Chelates
03/01/2007US20070049552 Fluoroquinolone formulations and methods of making and using the same
03/01/2007US20070049551 Method for enhancing mammalian immunological function
03/01/2007US20070049550 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
03/01/2007US20070049546 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals
03/01/2007US20070049544 Antisense IAP nucleobase oligomers and uses thereof
03/01/2007US20070049540 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor
03/01/2007US20070049539 Rsk inhibitors and therapeutic uses thereof
03/01/2007US20070049538 Methods for using cucurbitacin compounds
03/01/2007US20070049537 Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
03/01/2007US20070049534 Urinary track diseases; analgesics; antiinflammatory agents; gastrointestinal disorders; premenstrual tension; respiratory system disorders; incotinence
03/01/2007US20070049518 Novel method of treatment of inflammatory skin conditions
03/01/2007US20070049515 Therapeutic agent for diabetes containing insulin resistance improving agent
03/01/2007US20070049514 Resonance modulator for diagnosis and therapy
03/01/2007US20070048853 Carnitine palmitoyltransferase II crystals
03/01/2007US20070048782 Methods for assessing and treating leukemia
03/01/2007US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
03/01/2007US20070048397 Anti-inflammatory compositions and methods of use
03/01/2007US20070048396 Anti-inflammatory compositions and methods of use
03/01/2007US20070048395 Using centaurein for therapy of infection caused by bacteria such as Listeria, Brucella, Legionella, Francisella, or Mycobacterium
03/01/2007US20070048392 Plant extract mixtures and their uses
03/01/2007US20070048391 Composition for reduction of scar formation on wound scar
03/01/2007US20070048390 Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases
03/01/2007US20070048389 Vision defects; antiallergens; mixture contains source og hydrogen peroxide
1 ... 3856 3857 3858 3859 3860 3861 3862 3863 3864 3865 3866 3867 3868 3869 3870 3871 3872 3873 3874 3875 3876 ... 7860